We at Eugia Pharma Specialities Ltd., a wholly-owned subsidiary of Aurobindo Pharma, operate four state-of-the-art manufacturing facilities, with a fifth one currently under development. Our facilities are strategically located to serve global markets across the USA, Europe, Brazil, Mexico, Canada, Colombia, Australia, New Zealand, and select Rest of World (RoW) regions.

Our manufacturing units are designed to meet the highest international standards, ensuring the production of high-quality general injectables and oncology products. Each facility is equipped with advanced cutting-edge technologies and adheres to stringent regulatory compliances, including approvals from the US FDA and other global health authorities maintaining consistent excellence across our value chain.